Summary:
RSV vaccine study- A vaccine to prevent RESPIRATORY SYNCYTIAL VIRUS. The number two cause of lung infections in people over 60. Only 7 visits.
Qualified Participants May Receive:
Qualified participants will receive up to $700 for every completed study visit.